Sanofi India
- All
- News
- Videos
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Painkiller Combiflam Runs Into Trouble, Some Batches Withdrawn
The popular painkiller Combiflam is being withdrawn in batches in India after the country's drugs regulator found the lots were substandard, said the local unit of French drugmaker Sanofi.
-
Hope For India As World's First Anti-Dengue Vaccine Approved
At a time when India is struggling with rising number of dengue cases with each passing year, the Mexican government has approved the world's first anti-dengue vaccine which is designed to protect people in the 9-45 age group from nine to 45 years from all four subtypes of the virus.
-
India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
-
Vaccine Firm Warns Against Pakistan Polio Threat
The large cases of polio virus in Pakistan pose a threat to its neighbours such as India, the world's leading polio vaccine manufacturers has warned.
-
Sanofi to supply swine flu vaccine to US
Sanofi Pasteur on Monday said it has received order from the US health department to supply antigen for 27.3 million doses of Influenza A HINI 2009 monovalent vaccine for swine flu.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Painkiller Combiflam Runs Into Trouble, Some Batches Withdrawn
The popular painkiller Combiflam is being withdrawn in batches in India after the country's drugs regulator found the lots were substandard, said the local unit of French drugmaker Sanofi.
-
Hope For India As World's First Anti-Dengue Vaccine Approved
At a time when India is struggling with rising number of dengue cases with each passing year, the Mexican government has approved the world's first anti-dengue vaccine which is designed to protect people in the 9-45 age group from nine to 45 years from all four subtypes of the virus.
-
India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
-
Vaccine Firm Warns Against Pakistan Polio Threat
The large cases of polio virus in Pakistan pose a threat to its neighbours such as India, the world's leading polio vaccine manufacturers has warned.
-
Sanofi to supply swine flu vaccine to US
Sanofi Pasteur on Monday said it has received order from the US health department to supply antigen for 27.3 million doses of Influenza A HINI 2009 monovalent vaccine for swine flu.
